These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9500362)

  • 1. Issues about pertussis vaccines.
    Hurley S; Bennet J; Gust I
    Lancet; 1998 Feb; 351(9103):678; author reply 678-9. PubMed ID: 9500362
    [No Abstract]   [Full Text] [Related]  

  • 2. Issues about pertussis vaccines.
    Miller E; Eskola J
    Lancet; 1998 Feb; 351(9103):677-8; author reply 678-9. PubMed ID: 9500361
    [No Abstract]   [Full Text] [Related]  

  • 3. [New pertussis vaccines are tested].
    Hallander H; Wigzell H; Gothefors L; Olin P; Trollfors B
    Lakartidningen; 1992 Nov; 89(45):3820-2, 3825. PubMed ID: 1460993
    [No Abstract]   [Full Text] [Related]  

  • 4. [Compare pertussis vaccines--but do it accurately].
    Olin P; Hallander HO
    Lakartidningen; 1996 Feb; 93(7):603-4. PubMed ID: 8642927
    [No Abstract]   [Full Text] [Related]  

  • 5. [Protective effect of 2 acellular pertussis vaccines in a double-blind placebo controlled clinical trial].
    Kallings LO; Olin P; Storsaeter J
    Lakartidningen; 1988 Jun; 85(22):1994-6. PubMed ID: 3287070
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined acellular pertussis vaccines: new indication. No tangible benefit in primary vaccination.
    Prescrire Int; 2002 Jun; 11(59):73-5. PubMed ID: 12068840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placebo-controlled trial of two acellular pertussis vaccines in Sweden--protective efficacy and adverse events. Ad Hoc Group for the Study of Pertussis Vaccines.
    Lancet; 1988 Apr; 1(8592):955-60. PubMed ID: 2896826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.
    Thierry-Carstensen B; Dalby T; Stevner MA; Robbins JB; Schneerson R; Trollfors B
    Vaccine; 2013 Oct; 31(45):5178-91. PubMed ID: 23994021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Still more questions on pertussis vaccines.
    Poland GA
    Lancet; 1997 Nov; 350(9091):1564-5. PubMed ID: 9393330
    [No Abstract]   [Full Text] [Related]  

  • 11. Acellular pertussis vaccines: new preparation. Better tolerated but less active?
    Prescrire Int; 2000 Feb; 9(45):204-7. PubMed ID: 11503797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American Academy of Pediatrics Committee on Infectious Diseases: Family history of convulsions in candidates for immunization with pertussis-containing vaccines (diphtheria, tetanus, pertussis).
    Pediatrics; 1987 Nov; 80(5):743-4. PubMed ID: 3670978
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tolerance of acellular pertussis vaccine booster injection in 15-20-month-old children].
    Mallet E; Puyt A; Arson S; Surbled V
    Arch Pediatr; 2000 Apr; 7(4):410-4. PubMed ID: 10793931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The final spurt prior to general vaccination against whooping cough. More than 100 000 children participated in trials of 3 different vaccines].
    Wilhelmson B
    Lakartidningen; 1995 Jul; 92(30-31):2833-4. PubMed ID: 7643695
    [No Abstract]   [Full Text] [Related]  

  • 15. Acellular pertussis vaccine 63% to 92% effective.
    J Fam Pract; 2006 Jan; 55(1):12. PubMed ID: 16453953
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reactions to vaccination and serologic response to the pertussis component of diphtheria-tetanus-pertussis (DiTePer) vaccines in children].
    Adonajlo A; Plucińska E; Kozerska D; Czopik A; Rodkiewicz T; Jaworski Z; Kolloto-Szymajda B; Wagner K; Walter T
    Przegl Epidemiol; 1972; 26(4):453-64. PubMed ID: 4680437
    [No Abstract]   [Full Text] [Related]  

  • 17. Pertussis in older children and adults.
    Edwards KM
    Adv Pediatr Infect Dis; 1997; 13():49-77. PubMed ID: 9544307
    [No Abstract]   [Full Text] [Related]  

  • 18. Acellular pertussis vaccines in Japan: past, present and future.
    Watanabe M; Nagai M
    Expert Rev Vaccines; 2005 Apr; 4(2):173-84. PubMed ID: 15889991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The new pertussis vaccines are safe and efficient. With only few exceptions should all preschool children be vaccinated].
    Gothefors L; Berg R
    Lakartidningen; 1997 Nov; 94(45):4057-61. PubMed ID: 9424495
    [No Abstract]   [Full Text] [Related]  

  • 20. Invasive bacterial infections during an efficacy trial of acellular pertussis vaccines--implications for future surveillance in pertussis vaccine programmes.
    Olin P; Romanus V; Storsaeter J
    Tokai J Exp Clin Med; 1988; 13 Suppl():143-4. PubMed ID: 3078803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.